Gemcitabine trials for Pancreatic Cancer Metastatic

All Gemcitabine trials · All Pancreatic Cancer Metastatic trials

Phase breakdown

Recruiting trials studying Gemcitabine for Pancreatic Cancer Metastatic

• A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
  NCT07049055 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
  NCT07491445 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 33 locations
• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
  NCT05254171 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 93 locations

Common questions

How many trials study Gemcitabine for Pancreatic Cancer Metastatic?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.